Literature DB >> 22292375

[Analysis of using Danhong injection to treatment coronary heart disease patients medicines based on real world HIS database].

Jing Du1, Wei Yang, Danhui Yi, Yanming Xie, Wei Yang, Yan Zhuang, Qian Chen.   

Abstract

OBJECTIVE: To analyze the rules of medicinal groups that doctors treat angina pectoris using Danhong injection.
METHOD: Two thousands and seventy cases from hospital information system of 10 hospitals in Beijing 3a grade hospital were collected. Then use frequencies to find the most common drug and use association rules with apriori algorithm to analyze doctor's prescription compatibility rules curing coronary heart disease. RESULT: The compatibility among aspirin, oral nitrate, oral dose of clopidogrel and oral dose of Xintong was the most frequently used medicinal groups with Danhong injection in real world HIS database.
CONCLUSION: Danhong injection was used at treatment of coronary heart disease is often combination with similar pharmacological effects chemical drugs. Doctors should balance the benefits and the risks.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22292375

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  5 in total

1.  Danhong injection attenuates ischemia/reperfusion-induced brain damage which is associating with Nrf2 levels in vivo and in vitro.

Authors:  Hong Guo; Mei-jiao Li; Qing-qing Liu; Li-li Guo; Meng-meng Ma; Shao-xia Wang; Bin Yu; Li-Min Hu
Journal:  Neurochem Res       Date:  2014-07-29       Impact factor: 3.996

2.  Danhong Injection Price Trend and Its Utilization by Coronary Heart Disease Patients: Evidence From Hospital Records in China.

Authors:  Liming Liu; Yue Xu; Zihan Su; Xiaowei Man; Yan Jiang; Liying Zhao; Wei Cheng
Journal:  Front Pharmacol       Date:  2022-05-04       Impact factor: 5.988

3.  Danhong injection in the treatment of chronic stable angina: study protocol for a randomized controlled trial.

Authors:  Peng Qian Wang; Dan Dan Li; Wei Dong; Jun Liu; Ya Nan Yu; Chun Ti Shen; Qi Guang Chen; Bing Wei Chen; Yun Dai Chen; Zhong Wang
Journal:  Trials       Date:  2015-10-21       Impact factor: 2.279

4.  Danhong Injection Combined With t-PA Improves Thrombolytic Therapy in Focal Embolic Stroke.

Authors:  Min Li; Jing Zhou; Weifeng Jin; Xiaohong Li; Yuyan Zhang
Journal:  Front Pharmacol       Date:  2018-04-06       Impact factor: 5.810

5.  Danhong Injection Alleviates Mechanical Allodynia via Inhibiting ERK1/2 Activation and Elevates BDNF Level in Sciatic Nerve in Diabetic Rat.

Authors:  Qi Wang; Zhuang-Li Guo; Ge-Le Aori; Da-Wei Kong; Wen-Qiang Yang; Li Zhang; Yan-Bing Yu
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-14       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.